| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |